Literature DB >> 12036147

The validity of functional assessments of communication and the Activity/Participation components of the ICIDH-2: do they reflect what really happens in real-life?

Linda Worral1, Robyn McCooey, Bronwyn Davidson, Brigette Larkins, Louise Hickson.   

Abstract

UNLABELLED: This paper aims to provide a better understanding of the nature of functional communication activities so that assessment and treatment efforts are based on a theoretical framework and empirical data. Three sources of information are discussed. The first is the Activity/Participation dimensions of the World Health Organization's International Classification of Functioning, Disability, and Health. The second source is existing assessments of functional communication. The final source is data obtained from observational studies conducted in our research unit. The studies have observed the everyday communication of people with aphasia, people with Traumatic Brain Injury (TBI), and patients in hospital. The simplification of real-life communication in the WHO classification scheme, the variability of item sampling in existing assessments, and the complexity of communication observed in real-life settings has led to the conclusion that there are three levels of functional communication assessment: generic, population-specific, and individualized. Clinicians may choose which level suits their purpose. When clinicians routinely choose from a range of sophisticated functional assessments to inform their therapy, the seed that Martha Taylor Sarno planted and nourished for the past 30 years or more will truly flourish throughout the world of speech-language pathology. LEARNING OUTCOMES: As a result of this activity, participants will (1) understand the theoretical framework and data base that motivates assessment and treatment of functional communication activities, (2) be able to discuss the World Health Organization's Classification of Functioning, Disability and Health and (3) gain information about functional assessment and observational sampling of real world communication activities across three levels.

Entities:  

Mesh:

Year:  2002        PMID: 12036147     DOI: 10.1016/s0021-9924(02)00060-6

Source DB:  PubMed          Journal:  J Commun Disord        ISSN: 0021-9924            Impact factor:   2.288


  6 in total

1.  The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie
Journal:  J Commun Disord       Date:  2005 Sep-Oct       Impact factor: 2.288

2.  Developing and validating the Communication Function Classification System for individuals with cerebral palsy.

Authors:  Mary Jo Cooley Hidecker; Nigel Paneth; Peter L Rosenbaum; Raymond D Kent; Janet Lillie; John B Eulenberg; Ken Chester; Brenda Johnson; Lauren Michalsen; Morgan Evatt; Kara Taylor
Journal:  Dev Med Child Neurol       Date:  2011-06-27       Impact factor: 5.449

3.  Reaction time and cognitive-linguistic performance in adults with mild traumatic brain injury.

Authors:  Rocío S Norman; Manish N Shah; Lyn S Turkstra
Journal:  Brain Inj       Date:  2019-07-11       Impact factor: 2.311

4.  Variables associated with communicative participation in people with multiple sclerosis: a regression analysis.

Authors:  Carolyn Baylor; Kathryn Yorkston; Alyssa Bamer; Deanna Britton; Dagmar Amtmann
Journal:  Am J Speech Lang Pathol       Date:  2009-11-30       Impact factor: 2.408

5.  Developing the communicative participation item bank: Rasch analysis results from a spasmodic dysphonia sample.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie; Robert M Miller; Dagmar Amtmann
Journal:  J Speech Lang Hear Res       Date:  2009-08-28       Impact factor: 2.297

6.  Adaptation of The Scenario Test for Greek-speaking people with aphasia: A reliability and validity study.

Authors:  Marina Charalambous; Phivos Phylactou; Thekla Elriz; Loukia Psychogios; Jean-Marie Annoni; Maria Kambanaros
Journal:  Int J Lang Commun Disord       Date:  2022-05-12       Impact factor: 2.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.